These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21153445)

  • 1. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.
    ten Hoedt AE; de Sonneville LM; Francois B; ter Horst NM; Janssen MC; Rubio-Gozalbo ME; Wijburg FA; Hollak CE; Bosch AM
    J Inherit Metab Dis; 2011 Feb; 34(1):165-71. PubMed ID: 21153445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria - a randomized controlled trial.
    Trepp R; Muri R; Maissen-Abgottspon S; Haynes AG; Hochuli M; Everts R
    Am J Clin Nutr; 2024 Apr; 119(4):908-916. PubMed ID: 38569786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a four-week oral Phe administration on neural activation and cerebral blood flow in adults with early-treated phenylketonuria.
    Maissen-Abgottspon S; Steiner L; Muri R; Wijesinghe D; Jann K; Morishima Y; Hochuli M; Kreis R; Trepp R; Everts R
    Neuroimage Clin; 2024; 43():103654. PubMed ID: 39146838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial.
    Harding CO; Amato RS; Stuy M; Longo N; Burton BK; Posner J; Weng HH; Merilainen M; Gu Z; Jiang J; Vockley J;
    Mol Genet Metab; 2018 May; 124(1):20-26. PubMed ID: 29628378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large Neutral Amino Acids (LNAAs) Supplementation Improves Neuropsychological Performances in Adult Patients with Phenylketonuria.
    Scala I; Riccio MP; Marino M; Bravaccio C; Parenti G; Strisciuglio P
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.
    Schmidt E; Burgard P; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S82-6. PubMed ID: 8828617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study.
    Trefz FK; Burton BK; Longo N; Casanova MM; Gruskin DJ; Dorenbaum A; Kakkis ED; Crombez EA; Grange DK; Harmatz P; Lipson MH; Milanowski A; Randolph LM; Vockley J; Whitley CB; Wolff JA; Bebchuk J; Christ-Schmidt H; Hennermann JB;
    J Pediatr; 2009 May; 154(5):700-7. PubMed ID: 19261295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria.
    Pietz J; Landwehr R; Kutscha A; Schmidt H; de Sonneville L; Trefz FK
    J Pediatr; 1995 Dec; 127(6):936-43. PubMed ID: 8523192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.
    Smith ML; Hanley WB; Clarke JT; Klim P; Schoonheyt W; Austin V; Lehotay DC
    Arch Dis Child; 1998 Feb; 78(2):116-21. PubMed ID: 9579151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet.
    Lee PJ; Amos A; Robertson L; Fitzgerald B; Hoskin R; Lilburn M; Weetch E; Murphy G
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):631-5. PubMed ID: 19204028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
    Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
    Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
    Matalon R; Michals-Matalon K; Bhatia G; Burlina AB; Burlina AP; Braga C; Fiori L; Giovannini M; Grechanina E; Novikov P; Grady J; Tyring SK; Guttler F
    J Inherit Metab Dis; 2007 Apr; 30(2):153-8. PubMed ID: 17334706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.